Exchange: NASDAQ·Updated 07:56 PM EDT
BCDA logo

BCDA BioCardia Inc.

$1.15
$0.02
(1.71%)
Today
Closed $1.15
$0.0342
(2.97%)
After Hours
Reported EarningsAug 12
Mkt Cap$17.41M
Vol159,257.00

About BCDA

BioCardia, Inc. is a clinical-stage biotherapeutic company, which engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its pipeline includes CardiAMP, CardiALLO, PulmALLO, Helix Biotherapeutic Delivery System, and Morph DNA and AVANCE Steerable Introducers. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.
58

Bullish Sentiment

How do you feel about BCDA?

Advertisement|Remove ads.